Study to Evaluate the Safety, Pharmacokinetics and Tolerability of BMS-708163
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The primary objective is to assess the safety and tolerability of a single oral dose of
BMS-708163 in healthy young male subjects and in elderly male and female subjects.